Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chronic Optic Neuropathy in Multiple Sclerosis”

18 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 18 of 18 results

Testing effectiveness (Phase 2)UnknownNCT01228396
What this trial is testing

AIMSPRO in the Treatment of Bladder Dysfunction in Secondary Progressive Multiple Sclerosis

Who this might be right for
Secondary Progressive Multiple Sclerosis
Daval International Limited 20
Not applicableLooking for participantsNCT06502015
What this trial is testing

Biomarkers in Autoimmune Disease of Nervous System

Who this might be right for
Autoimmune Diseases of the Nervous SystemNeuromyelitis Optica Spectrum DisorderMultiple Sclerosis+8 more
Tongji Hospital 50,000
Not applicableLooking for participantsNCT07653984
What this trial is testing

Cohort Study on Neuroimmune Diseases in the Reproductive Age

Who this might be right for
Neuromyelitis Optica Spectrum Disorders (NMOSD)Multiple SclerosisAutoimmune Encephalitis+3 more
Third Affiliated Hospital, Sun Yat-Sen University 100
Not applicableLooking for participantsNCT05204459
What this trial is testing

MS-ResearchBiomarkerS

Who this might be right for
Multiple SclerosisMultiple Sclerosis, Relapsing-RemittingMultiple Sclerosis, Primary Progressive+8 more
Cedars-Sinai Medical Center 1,000
Testing effectiveness (Phase 2)Ended earlyNCT03536559
What this trial is testing

Nanocrystalline Gold to Treat Remyelination Failure in Chronic Optic Neuropathy In Multiple Sclerosis

Who this might be right for
Relapsing Remitting Multiple SclerosisOptic NeuropathyOptic; Neuritis, With Demyelination
Clene Nanomedicine 73
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07804004
What this trial is testing

A Safety and Efficacy Study Evaluating CTX112 in Subjects With Refractory Neurologic Autoimmune Disease

Who this might be right for
Progressive Multiple Sclerosis (PMS)Neuromyelitis OpticaMyelin Oligodendrocyte Glycoprotein Antibody-associated Disease+2 more
CRISPR Therapeutics 220
Not applicableUnknownNCT06443333
What this trial is testing

National, Multicentric Registry Study on Neuroimmunological Diseases in China

Who this might be right for
Multiple SclerosisNMO Spectrum DisorderMyelin Oligodendrocyte Glycoprotein Antibody-associated Disease+3 more
Xuanwu Hospital, Beijing 7,000
Very early researchLooking for participantsNCT06939166
What this trial is testing

Universal Chimeric Antigen Receptor T-Cell （UCAR T-cell） Therapy Targeting CD19/B Cell Maturation Antigen （CD19/BCMA） in Patients With r/r Neurological Autoimmune Diseases

Who this might be right for
Neuromyelitis Optica Spectrum DisordersMyasthenia GravisMultiple Sclerosis+2 more
Tianjin Huanhu Hospital 12
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07826689
What this trial is testing

A Phase 1/2a Study of Oral PRO-1562 in Healthy Subjects and Patients With Relapsing Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Progentos Therapeutics 160
Not applicableStudy completedNCT02543788
What this trial is testing

CHRONIC OPTIC NEUROPATHY IN MULTIPLE SCLEROSIS

Who this might be right for
Chronic Optic Neuropathy in Multiple Sclerosis
Hospices Civils de Lyon 39
Not applicableActive Not RecruitingNCT03655223
What this trial is testing

Early Check: Expanded Screening in Newborns

Who this might be right for
Spinal Muscular AtrophyFragile X SyndromeFragile X - Premutation+182 more
RTI International 30,000
Early research (Phase 1)Looking for participantsNCT06680037
What this trial is testing

Assess the Safety and Clinical Activity of Azer-cel in Participants With B-cell Mediated Autoimmune Disorders

Who this might be right for
B-cell Mediated Autoimmune Disorders
TG Therapeutics, Inc. 100
Early research (Phase 1)Looking for participantsNCT07085676
What this trial is testing

Phase 1 Study of HBI0101 CAR-T in Refractory B-Cell Autoimmune Diseases

Who this might be right for
Systemic Sclerosis (SSc)Idiopathic Inflammatory Myopathy (IIM)Rheumatoid Arthritis (RA)+6 more
Polina Stepensky 120
Not applicableStudy completedNCT03942952
What this trial is testing

PEDIATRIC SONICS: Pediatric Study of Neuropsychology and Imaging in CNS Demyelinating Syndromes.

Who this might be right for
Multiple Sclerosis, Relapsing-RemittingNeuromyelitis OpticaAcute Disseminated Encephalomyelitis+1 more
University of Texas Southwestern Medical Center 49
Early research (Phase 1)Looking for participantsNCT07526493
What this trial is testing

Safety and Pharmacodynamics of QH103 Cell Injection in the Treatment of Patients With Relapsed/Refractory Antibody-Mediated Neurological Autoimmune Diseases.

Who this might be right for
Multiple Sclerosis (MS)Neuromyelitis Optica Spectrum Disorder (NMOSD)Autoimmune Encephalitis (AE)+4 more
Tongji Hospital 6
Large-scale testing (Phase 3)UnknownNCT02220244
What this trial is testing

Effect of MD1003 in Chronic Visual Loss Related to Optic Neuritis in Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
MedDay Pharmaceuticals SA 105
Very early researchNot Yet RecruitingNCT06485232
What this trial is testing

Universal CAR-T Cells in Patients with Refractory Autoimmune Diseases of the Nervous System.

Who this might be right for
Neuromyelitis Optica Spectrum DisordersMyasthenia Gravis, GeneralizedMultiple Sclerosis+1 more
Xuanwu Hospital, Beijing 25
Not applicableStudy completedNCT04289909
What this trial is testing

Identification of Retinal Perivascular Inflammation in Patients With Multiple Sclerosis Using Adaptive Optics (RETIMUS)

Who this might be right for
Relapsing Remitting Multiple SclerosisProgressive Multiple SclerosisOptic Neuritis+4 more
Institut National de la Santé Et de la Recherche Médicale, France 50